---
title: "Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294914828.md"
description: "Jin Medical International (ZJYL) shares surged over 63% in after-hours trading following its Q2 financial results. Despite a 9.7% revenue decline to $8.9 million due to weaker demand from key customer Nissin, the company reported improved gross margins rising to 26.9%. The firm posted a net loss of $0.2 million and held $9.1 million in cash. CEO Erqi Wang highlighted stable core product revenue and enhanced operating efficiency."
datetime: "2026-08-05T04:18:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294914828.md)
  - [en](https://longbridge.com/en/news/294914828.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294914828.md)
generator: "portal-rs"
---

# Jin Medical International (ZJYL) Stock Soars Over 63% After Hours: Here's What You Need To Know

**Jin Medical International Ltd.** (NASDAQ:ZJYL) shares surged 63.41% to $3.17 in after-hours trading following the announcement of its unaudited financial results for the six months ended Mar. 31.

## Revenue Slips, But Margins Tell a Different Story

The China-based rehabilitation equipment maker said after the market closed on Tuesday that its revenue fell 9.7% from a year earlier to $8.9 million. The decline was driven by weaker demand from its biggest customer, medical device distributor Nissin, because of the weaker Japanese yen and the suspension of electric scooter sales. Even so, its gross margin increased to 26.9% from 24.3%, while wheelchair component sales rose 9.9%.

The company reported a net loss of $0.2 million, versus net income of $0.01 million a year earlier.

According to Jin Medical International, the company held $9.1 million in cash and $21 million in short-term investments for the period.

Research and development expenses jumped 33.4% to $0.9 million, reflecting the company’s push toward product innovation. Basic and diluted loss per share stood at $0.01, unchanged from a year earlier.

CEO **Erqi Wang** said, “Nevertheless, revenue from our core wheelchair products remained relatively stable, wheelchair component sales increased, and our gross margin improved to 26.9% as we continued to enhance inventory management and operating efficiency.”

## **Trading Metrics, Technical Analysis**

Jin Medical International has a market capitalization of approximately $15.19 million. Its stock has traded between a 52-week high of $17.18 and a 52-week low of $1.64.

ZJYL has a Relative Strength Index (RSI) of 44.77.

On Tuesday, Jin Medical International saw elevated trading activity, with volume reaching 5.78 million shares, about 327.3 times its average daily volume of 17,660 shares.

Over the past 12 months, the stock has fallen 84.86%.

Currently, the stock is trading close to its annual low.

**Price Action:** The healthcare stock closed the regular session on Tuesday at $1.94, up 0.52%, according to Benzinga Pro data.

**Benzinga’s Edge Stock Rankings** indicates ZJYL stock has a negative price trend across all time frames.

***Disclaimer:*** *This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.*

 **Read Also: AppLovin (APP) Stock Jumps Over 3% After Hours: Here's Why It Is Trending** 

*Photo Courtesy: prassarp on Shutterstock.com*

### Related Stocks

- [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md)
- [APP.US](https://longbridge.com/en/quote/APP.US.md)

## Related News & Research

- [Erqi Wang Discloses Investment at Jin Medical International with 6.77% Stake](https://longbridge.com/en/news/296651200.md)
- [Jin Medical International Completes VIE Deal and Expands Share Base in July 2026](https://longbridge.com/en/news/294884921.md)
- [Canopy Growth publishes FY2026 annual report](https://longbridge.com/en/news/296603480.md)
- [09:30 ETHealthWell Foundation Announces Panel Sessions at the 2026 Healthcare Advocate Summit](https://longbridge.com/en/news/296364095.md)
- [Liquidia Chief Medical Officer Rajeev Saggar disposes of USD 5.97 million in common shares](https://longbridge.com/en/news/296406687.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**